Lifeward vs Jin Medical International
Lifeward reported revenue of $22 million in fiscal 2025, about the same as Jin Medical International's $21 million in fiscal 2025. Lifeward's revenue fell 14.1% in its latest year, and Jin Medical International's fell 12.0%. Lifeward had an operating margin of -89.3%, against 2.9% at Jin Medical International. Free cash flow was −$17 million at Lifeward and −$4 million at Jin Medical International. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.
Side by side
| Lifeward | Jin Medical International | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Sep 30, 2025 |
| Revenue | $22M | $21M |
| Revenue growth | −14.1% | −12.0% |
| Revenue growth a year, last 5 years | 38.0% | — |
| Gross margin | 38.2% | 29.2% |
| Operating margin | −89.3% | 2.9% |
| Net margin | −90.4% | 5.8% |
| Free cash flow | −$17M | −$4M |
| Free cash flow margin | −76.4% | −18.0% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 60.2% | 0.1% |
| Last close | $2.95 | $3.34 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
LifewardJin Medical International
Operating margin
Percent of revenue
LifewardJin Medical International
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
LifewardJin Medical International
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Lifeward and Jin Medical International pages.